Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129240) titled 'Protein Modifications and Sepsis Research' on Aug. 1.

Study Type: Observational study

Study Design: Case study

Primary Sponsor: The Second Hospital,University of South China

Condition: Sepsis

Intervention: Sepsis group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Sepsis group:300;Healthy control group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=335015

Published by HT Digital Content Services with permission from Health Daily Digest....